 Penumbra Inc NYSE: PEN reported Q2 sales of 184.3 million, an increase of 75.3 YY, or 72.7 on a constant currency basis, beating the consensus of 170.76 million. Revenue from sales of vascular products grew to 100.7 million, 117.6, or 115.8 on a constant currency basis. 